首页 | 本学科首页   官方微博 | 高级检索  
     

bcl—2,c—erbB—2在胃粘膜癌变过程中的表达及意义
引用本文:施琳,乌新林,李晓洁,冀文茹,夏养志. bcl—2,c—erbB—2在胃粘膜癌变过程中的表达及意义[J]. 内蒙古医学院学报, 2001, 23(1): 5-8
作者姓名:施琳  乌新林  李晓洁  冀文茹  夏养志
作者单位:1. 内蒙古医学院病理教研室,内蒙古,呼和浩特,010059
2. 内蒙古医学院第一附属医院普外科
3. 呼和浩特新城区卫生防保站
摘    要:目的:通过检测bcl-2,c-erbB-2基因在胃粘膜良恶生病变中的表达,探讨其对提高胃癌诊断率的作用。方法:采用免疫组化SABC法,检测bcl-2,c-erbB-2基因在98例胃癌,40例不典型增生和20例正常胃粘膜中的表达,结果a,bcl-2在正常胃粘膜中有弱阳性表达(10.0%),在不典型增生中为50%,在胃癌中为44.9%,不典型增生与胃癌中的表达均显著高于正常胃粘膜(P<0.05),bcl-2表达与胃癌的分化程度有关(P<0.05),低分化者bcl-2表达率高,与淋巴结转移,浸润深度无关(P>0.05),b.c-erbB-2在胃癌中的阳性表达率为56.1%,其中中早期胃癌中的表达低(16.7%),在重度不典型增生和进展期胃癌中的表达高,分别为80%,58.7%,二者与早期胃癌比较有统计学意义(P<05),c-erbB-2表达与浸润深度,淋巴结转移有关(P<0.05),与分化程度无关(P>0.05),结论: -2,-B-2c参与胃粘膜的癌变过程,联合检测bcl-2,c-erbB-2可能作为胃癌高危人群筛选的有效指标。

关 键 词:胃癌 bcl-2 c-erbB-2 免疫组化
文章编号:1004-2113(2001)01-0005-04
修稿时间:2000-11-21

THE EXPRESSION OF bcl-2,c-erbB-2 AND ITS SIGNIFICANCE IN THE DEVELOPMENT OF GASTRIC CANCER
SHI Lin,WU Xin-lin,LI Xiao-jie,JI Wen-ru,XIA Yang-zhi. THE EXPRESSION OF bcl-2,c-erbB-2 AND ITS SIGNIFICANCE IN THE DEVELOPMENT OF GASTRIC CANCER[J]. Acta Academiae Medicinae Neimongol, 2001, 23(1): 5-8
Authors:SHI Lin  WU Xin-lin  LI Xiao-jie  JI Wen-ru  XIA Yang-zhi
Abstract:Objective:To detect the expression of bcl-2 and c-erbB-2 in gastric mucosa of benign and malignant lesions and estimate its diagnosis value. Methods:Using S-P method. Results:a. The positive rate of bcl-2 expression was 10%, 50% and 44.9% in normal gastric mucosa, atypical hyperplasia and gastric cancer respectively. Significant difference was seen between the two groups and normal gastric mucosa(P<0 05). There was relationship between bcl-2 expression and differentiation of gastric cancer, but bcl-2 expression was not related with lymphnode metastasis(LNM) and depth of infiltration. b. The expression of c-erbB-2 gene was found in gastric cancer (56.1%) and low in early stage(16.7%), but high in the advanced stage(58.7%), the heavy atypical hyperplasia(80%), there was a significant difference between the two groups and the early stage of gastric cancer (P<0 05). The expression of c-erbB-2 had something to do with LNM depth of infiltration(P<0 05) and nothing to do with differentiation(P>0 05). Conclusion:bcl-2 and c-erbB-2 may be involved in the course of stomach carcinogenesis, detecting the expression of bcl-2 and c-erbB-2 may be a useful marker for identifying patients at high risk of developing gastric cancer.
Keywords:cancer   stomach  bcl-2  c-erbB-2  immunohistochemistry
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号